AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02407951 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psycho-Educational group
Description: Child group: 8 weekly group sessions lasting 90 mins each, as well as additional three monthly booster sessions afterwards.~During the educational group sessions, each session will focus on educating the participants in regard to a specific subject: Tourette syndrome, Self-esteem, Anger, OCD (obssesive compulsive disorder), School and bullying, Anxiety, Attention, and a final session Quiz.~Parent group: Parent-group sessions will simultaneously run during the first 4 sessions of the child-group. The parents-group will include psycho-education and the use of reward strategies.~All group meetings will be executed and managed by two trained clinicians.
Study NCT02840487 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-ZKADNA085-00-VP
Description: VRC-ZKADNA085-00-VP is an investigational ZIKV DNA vaccine that is intended to prevent Zika virus infection.
Study NCT04906655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glycopyrronium 2.4 % Medicated Cloth
Description: The investigational product (glycopyrronium cloth, 2.4%) is a pre-moistened, medicated cloth towelette that comes in individually wrapped packets. Subjects will receive marketed Qbrexza, one box, containing 30 pouches.
Study NCT03689283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: Individuals randomized to the Dry Needling Group will receive dry needling to latent trigger points of the gastrocnemius muscle
Study NCT03689283 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Dry Needlling
Description: Individuals randomized to the Control group will receive sham needling to the gastrocnemius muscle
Study NCT01840020 — intervention group
Intervention type: PROCEDURE
Intervention: Gastric bypass
Description: Surgical procedure in which the stomach is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the small intestine by an end-to-side surgical anastomosis.
Study NCT01840020 — intervention group
Intervention type: PROCEDURE
Intervention: gastric sleeve
Description: Sleeve gastrectomy, a surgical procedure in which the stomach is reduced to about 25% of its original size, by surgical removal of a large portion of the stomach, following the major curve. The open edges are then attached together (often with surgical staples) to form a sleeve or tube with a banana shape.
Study NCT01340235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral erythromycin
Description: Severe Dowling Meara EBS patients from 6 months to 8 years old
Study NCT03235544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Parsaclisib
Description: Parsaclisib tablets administered orally with water and without regard to food.
Study NCT01833273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PolyMVA
Description: Subjects will take 8 tsp/day of PolyMVA over a 26 week period while receiving standard of care from his/her neuro-oncologist. Subjects will begin taking the study compound after maximal surgical resection of the tumor and receiving an initial treatment of radiation therapy. Subjects will not take study compound on days when they receive chemotherapy.
Study NCT00977327 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Intraoperative MR (PoleStar N-20, Medtronics)
Description: intraoperative imaging for resection control of intraaxial brain lesions
Study NCT00977327 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Intraoperative Ultrasound (Sonowand, Mison)
Description: intraoperative imaging for resection control of intraaxial brain lesions
Study NCT02544971 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: Neurofeedback is based on the learned change in a particular neural signal or a combination of neural signals when feedback and reward of these signals are repeatedly presented to the organism. Thus, individuals learn to modulate their neural activity through a closed NF loop.
Study NCT02544971 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neurofeedback
Description: Neurofeedback is based on the learned change in a particular neural signal or a combination of neural signals when feedback and reward of these signals are repeatedly presented to the organism. Thus, individuals learn to modulate their neural activity through a closed NF loop.
Study NCT02544971 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Treatment as usual
Study NCT03963245 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meaningful Activities and Recovery
Description: MA\&R is a new rehabilitation program for people with psychiatric disabilities. MA\&R aims to enable participation in everyday activities that are meaningful to the individual.~MA\&R is based on occupational science, and the underlying premise that there is a connection between mental health, recovery and meaningful everyday activities. The goal of MA\&R is that participants through the course become better at connecting daily activities with values, interests, plans and goals. When this connection is strengthened, it supports the experience of meaningfulness in everyday life.~MA\&R is led by two mentors where one mentor is an occupational therapist (or similar) and the other has lived experiences of mental vulnerability and recovery.
Study NCT03963245 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care and Treatment
Description: For community mental health centres: medicine, psychoeducation, relational support, peer-support, psychotherapy, social counselling, care manager~For psychiatric rehabilitation services in Copenhagen, Odense and Svendborg: drop in centres, relational support, skills training, peer-support
Study NCT03963245 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Care and Treatment
Description: For community mental health centres: medicine, psychoeducation, relational support, peer-support, psychotherapy, social counselling, care manager~For psychiatric rehabilitation services in Copenhagen, Odense and Svendborg: drop in centres, relational support, skills training, peer-support
Study NCT03825367 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Nivolumab
Description: The dose of Nivolumab will be 3 mg/kg which is the adult recommended dose and is the recommended dose in children in the phase 2 portion of COG ADVL1412.~If 3 mg/kg is not tolerated in combination with 5-azacytidine, the dose will be stepped down to 1 mg/kg.
Study NCT03825367 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 5-azacytidine
Description: 75mg/m2 subcutaneously will be given daily for 7 days on days 1 to 7.
Study NCT04021758 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer to peer program intervention
Description: Peer to peer suicide prevention program aimed at reducing suicide in a military population.
Study NCT01275976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: C1-esterase inhibitor
Description: C1-esterase inhibitor 200 U/kg infusion over 30 minutes, just before the start of the femur or pelvic fixation operation.
Study NCT01275976 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline 0.9%
Description: Infusion, just before the start of the femur or pelvic fixation operation
Study NCT00700245 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise-only (EXO-12 weeks of regular supervised exercise without diet restriction)
Description: The exercise intervention for subjects in the EXO consisted of supervised aerobic exercise three times per week with a duration of 60 -75 minutes pr. training session, with an estimated energy expenditure of 500-600 kcal per session. The subjects could choose between different modes of exercise; stationary bicycling, jogging on a treadmill or stair stepping.
Study NCT00700245 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet-only (DIO-8 weeks of very low energy diet (VLED 600 kcal/d) followed by 4 weeks weight maintenance diet
Description: Subjects in the DIO group were prescribed a liquid VLED(Nupo, Copenhagen) of respectively 600 and 800 kcal pr. day (proteins 41 g, carbohydrates 29 g, fat 5.6 g. pr 100 gram) for eight weeks followed by a weight maintenance diet for four weeks.
Study NCT00700245 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet+exercise (DEX-8 weeks VLED 800 kcal/d + a four weeks weight maintenance diet combined with regular supervised exercise throughout the 12 weeks).
Description: The exercise intervention for subjects in the DEX group consisted of supervised aerobic exercise three times per week with a duration of 60 -75 minutes pr. training session, with an estimated energy expenditure of 500-600 kcal per session
Study NCT01736748 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensor based PA intervention
Description: Children will be equipped with a heart rate monitor, a GPS receiver and an accelerometer for collection of heart rate, mobility and physical activity free-living data during a 7-day period. This will provide a 'spatio-behavioural diagnosis' using a map-based interactive web application. This data will be used to developed a tailored plan to promote physical activity in the child's every day environment.
Study NCT01736748 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Traditional PA counseling
Description: Children will be encouraged to enhance their physical activity levels using traditional behavioral approaches.
Study NCT01910337 — intervention group
Intervention type: DEVICE
Intervention: Use the Polar Cardiac rate meter
Study NCT01150006 — intervention group
Intervention type: OTHER
Intervention: Cross sectional study
Description: This is not intervention study. The purpose of the study is to examine the relationship between various adipokine levels and PET imaging at the cross section setting
Study NCT03417609 — intervention group
Intervention type: DEVICE
Intervention: Tongue strength measurement
Description: The Iowa Oral Performance Instrument is a validated device for assessing the strength of the tongue. This involves placing the tip of a tube in the mouth and asking the patient to exert pressure on it.
Study NCT03417609 — intervention group
Intervention type: PROCEDURE
Intervention: Blood sampling
Description: Blood sampling
Study NCT03417609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Mini Mental State Examination (MMSE)
Description: Also called Folstein test, it is an assessment of the patient cognitive and memory functions. It detects cognitive disorders or dementia. The MMSE is quickly realizable and explores several cognitive functions through 30 questions divided into 7 items.
Study NCT03417609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Minimal nutritional assessment (MNA-SF)
Description: The minimal nutritional assessment - short form is a simple, non - invasive and validated scale for the detection of malnutrition in the elderly patient.
Study NCT03417609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Dual-energy x-ray absorptiometry (DEXA)
Description: Dual-energy x-ray absorptiometry (DEXA) is the imaging technique recommended for the diagnosis of sarcopenia.
Study NCT03417609 — intervention group
Intervention type: DEVICE
Intervention: Dynamometer (Hand grip )
Description: By placing a dynamometer in the patient's hand and asking him to apply maximum pressure to it, the muscular strength of the extremities of the limbs is estimated.
Study NCT03417609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Walking speed
Description: Walking speed evaluates the muscular performance. The seated patient must get up and walk a distance of 6 meters as quickly as possible without the help of a third party.
Study NCT00664287 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: niacin (+) laropiprant
Description: Group 1: Patients will receive ER niacin/laropiprant 1 g/20 mg daily. After 4 weeks, ER niacin/laropiprant will be increased to 2 g/40 mg for remainder of study.
Study NCT00664287 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo (unspecified)
Description: Group 2: Patients will receive 1 placebo tablet daily. After 4 weeks, patients will be advanced to 2 placebo tablets for remainder of the study.
Study NCT03635983 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NKTR-214
Description: Specified dose on specified days
Study NCT03635983 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Specified dose on specified days
Study NCT04735107 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: colorectal anastomosis reinforcement and trans-anal drainage
Description: Circular mucosal flap created to cover stapled anastomosis + vacuum sponge drainage
Study NCT00817141 — intervention group
Intervention type: OTHER
Intervention: Observational study, no intervention
Description: Observation of the complications seen without urinary catheter (which is the habitual protocol in our institution)
Study NCT01719978 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3.6mL 2% Mepivacaine with 1:100,000 epinephrine
Description: Local anesthetic with vasoconstrictor
Study NCT01719978 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3.6mL 2% Mepivacaine with 1:100,000 epinephrine
Description: Local anesthetic with vasoconstrictor
Study NCT01719978 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lower Third Molar Extraction
Description: Lower Third Molar Extraction with LA + hyaluronidase (or placebo)
Study NCT01719978 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Lower Third Molar Extraction
Description: Lower Third Molar Extraction with LA + hyaluronidase (or placebo)
Study NCT01719978 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronidase
Description: 75RTU Hyaluronidase administration concomitant to the local anesthetic
Study NCT03523845 — intervention group
Intervention type: OTHER
Intervention: Observational intervention to diagnose an early apical peri-implantitis
Description: diagnose an early apical peri-implantitis
Study NCT00894517 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Description: OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1.
Study NCT00894517 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (saline)
Description: Saline injected into the prostate on Day 1.
Study NCT00460109 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: denileukin diftitox
Study NCT00460109 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rituximab
Study NCT02095340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positive Interpretation Bias Training
Study NCT02095340 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Neutral Interpretation Bias Training
Study NCT03946917 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS001
Description: JS001 3 mg/kg, iv drip, d1, d15, q4w
Study NCT03946917 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: regorafenib tablet
Description: 80/120/160 mg, po, d1-d21, Q4w.
Study NCT03860337 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alginate Sausage
Description: Alginate sausage
Study NCT03860337 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Sausage
Description: Control Sausage
Study NCT00703131 — intervention group
Intervention type: DEVICE
Intervention: Anal Fistula Plug (SurgiSIS AFP)
Description: Anal Fistula Plug
Study NCT04244799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral nudges
Description: Behavioral nudges include the following:~1. Colorful pathway overlaid with footprints leading from the toilet to the handwashing station~2. Rotating posters in toilet areas with messages targeting behavioral motivators for handwashing (disgust, social affiliation)~3. Sticker of a pair of eyes placed above the handwashing station~4. Soap dish with an arrow beside it on the sink or counter to remind children to wash their hands with soap
Study NCT04244799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: National WASH policy
Description: The Philippines' Department of Education National WASH in Schools (WinS) policy promotes correct hygiene and sanitation practices among school children and a clean environment in and around schools and includes initiatives related to infrastructure, knowledge, and behavior change, but does not include other programs with an explicit focus on handwashing promotion.
Study NCT04244799 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: National WASH policy
Description: The Philippines' Department of Education National WASH in Schools (WinS) policy promotes correct hygiene and sanitation practices among school children and a clean environment in and around schools and includes initiatives related to infrastructure, knowledge, and behavior change, but does not include other programs with an explicit focus on handwashing promotion.
Study NCT01719978 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1mL 0.9% saline administration concomitant to the local anesthetic
Study NCT03400566 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Narrative
Description: Children will be read a story book featuring vegetables for a minimum of 7 times (including twice during the familiarization phase).
Study NCT03400566 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative
Description: Children will be read a story book featuring vegetables for a minimum of 7 times (including twice during the familiarization phase).
Study NCT03400566 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Experiential
Description: Children will receive hands on experience with the vegetable. They will get to listen, see, feel, touch and smell the actual vegetable during the two familiarization phases.
Study NCT03400566 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiential
Description: Children will receive hands on experience with the vegetable. They will get to listen, see, feel, touch and smell the actual vegetable during the two familiarization phases.
Study NCT01820065 — intervention group
Intervention type: PROCEDURE
Intervention: Cataract surgery with IOL implantation
Description: Phacoemulsification with implantation of single piece Acrysof IOL
Study NCT01723657 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ara-C
Description: * Intermediate dose during induction phase to remission.~* High dose during consolidation phase in patients with favorable cytogenetics and leukocyte index below 20.
Study NCT01723657 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Autologous peripheral blood stem cell transplantation.
Description: * In patients with favorable cytogenetics with a Leukocyte index above 20.~* Patients with normal karyotype, and one cycle of chemotherapy to achieve complete remission, without adverse molecular and/or minimal residual disease (MRD) characteristics, regardless availability of a matched donor.
Study NCT01723657 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Allogeneic matched related or unrelated donor transplant.
Description: -Patients without favorable/intermediate characteristics.
Study NCT01723657 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: G-CSF
Description: * Administration at induction phase to remission, days 0 to 7. G-CSF will not be initiated if the leukocyte count is over 30x10e9/L at diagnosis or will be interrupted if the leukocyte count during treatmen arises 30x10e9/L.~* Administration at consolidation phase, days 4 to 6 (3 doses). G-CSF will be interrupted if the leukocyte count during treatment arises 30x10e9/L.
Study NCT01723657 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CD34+ selection.
Description: -Patients with adverse prognosis with allogeneic peripheral blood stem cell (PBSC)tranplantation, CD34+ cell selection of the inoculum was performed.
Study NCT01723657 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Mylotarg purging before autologous PBSC transplantation
Description: Patients without favorable/intermediate characteristics and without matched related donor.
Study NCT03881670 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Lotrafilcon B
Description: commercially available contact lens
Study NCT03881670 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lotrafilcon B
Description: commercially available contact lens
Study NCT03881670 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: lotrafilcon B with Hydraluxe
Description: commercially available contact lens
Study NCT03881670 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: lotrafilcon B with Hydraluxe
Description: commercially available contact lens
Study NCT00381550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: Given IV
Study NCT00381550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triapine
Description: Given IV
Study NCT00381550 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative study
Study NCT01931930 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Perilla extract
Study NCT01931930 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Study NCT00837356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Advate®
Description: Subjects will receive Advate® at a dose of 50 IU/kg body weight in the first session
Study NCT00837356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: turoctocog alfa
Description: After a washout period of 4 days, subjects will subsequently receive turoctocog alfa (recombinant factor VIII (N8)) at a dose of 50 IU/kg body weight in the second session
Study NCT04426708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMS5552
Description: single dose of HMS5552 25mg